Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $145.0500 (-2.66%) ($145.0500 - $145.0500) on Thu. Feb. 18, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.8% (three month average) | RSI | 32 | Latest Price | $145.0500(-2.66%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -7.5% a day on average for past five trading days. | Weekly Trend | LGND declines -6.5% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(58%) IWO(57%) IWM(53%) IWC(52%) XBI(52%) | Factors Impacting LGND price | LGND will decline at least -2.4% in a week (0% probabilities). VIXM(-27%) UUP(-17%) VXX(-16%) UNG(-3%) TBT(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.4% (StdDev 4.8%) | Hourly BBV | -1 () | Intraday Trend | 0% | | | |
|
Inflection Point | Yes | Resistance Level | $174.85 | 5 Day Moving Average | $161.26(-10.05%) | 10 Day Moving Average | $181(-19.86%) | 20 Day Moving Average | $174.85(-17.04%) | To recent high | -32.8% | To recent low | 78.2% | Market Cap | $2.331b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |